Max Robotics — Global Service Robot Directory + US Certification

About

Safi Dokmak is a distinguished hepato-pancreato-biliary (HPB) surgeon and clinical researcher whose work centers on minimally invasive pancreatic surgery, surgical technique optimization, and perioperative outcomes. His research has made meaningful contributions to understanding the complexities of laparoscopic and robotic pancreatectomy, particularly in identifying risk factors that influence surgical decision-making and patient safety. His notable work on minimally invasive left pancreatectomy addresses one of the field's persistent challenges — intraoperative conversion — by developing a practical Conversion Risk Score (CRS) designed to help surgeons stratify patient risk preoperatively and better anticipate complications. This tool has the potential to improve surgical planning, informed consent processes, and ultimately postoperative outcomes for patients undergoing complex pancreatic resections. Though his publication record continues to grow, with recent work already attracting early citations, Dokmak's research reflects a commitment to evidence-based surgical practice and continuous refinement of minimally invasive techniques. His contributions position him as an emerging and important voice in the HPB surgery community, advancing the field's understanding of how to make complex pancreatic procedures safer and more predictable for both surgeons and patients.